glipizide has been researched along with Glycosuria in 8 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Glycosuria: The appearance of an abnormally large amount of GLUCOSE in the urine, such as more than 500 mg/day in adults. It can be due to HYPERGLYCEMIA or genetic defects in renal reabsorption (RENAL GLYCOSURIA).
Excerpt | Relevance | Reference |
---|---|---|
" Post-dose glipizide concentrations were three times higher than those of glibenclamide, due to the incomplete bioavailability of the latter." | 2.66 | Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. ( Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E, 1985) |
" Mean initial dosage was 7." | 2.64 | Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study. ( Fowler, LK, 1978) |
"The clinically effective duration of blood glucose lowering action of a new hypoglycaemic sulphonylurea, glipizide, given in single before breakfast dosage (up to 20 mg) has been studied in 20 apparently insulin-independent diabetics." | 2.64 | [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)]. ( Azzopardi, J; Campbell, IW; Clarke, BF; Duncan, LJ, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nauck, M | 1 |
Del Prato, S | 1 |
Rosak, C | 1 |
Forst, T | 1 |
Culler, FL | 1 |
McKean, LP | 1 |
Buchanan, CN | 1 |
Caplan, DB | 1 |
Meacham, LR | 1 |
Fowler, LK | 1 |
Azzopardi, J | 1 |
Campbell, IW | 1 |
Clarke, BF | 1 |
Duncan, LJ | 1 |
Cochet, B | 1 |
Balant, L | 1 |
Rilliet, B | 1 |
Zahnd, G | 1 |
Salo, S | 1 |
Groop, L | 2 |
Wåhlin-Boll, E | 1 |
Groop, PH | 1 |
Tötterman, KJ | 1 |
Melander, A | 1 |
Tolppanen, EM | 1 |
Fyhrqvist, F | 1 |
1 review available for glipizide and Glycosuria
Article | Year |
---|---|
[Glycosuria with SGLT-2 inhibitors--a new treatment approach for type 2 diabetes mellitus].
Topics: Benzhydryl Compounds; Canagliflozin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Thera | 2012 |
4 trials available for glipizide and Glycosuria
Article | Year |
---|---|
Glipizide in the treatment of maturity-onset diabetes: a multi-centre, out-patient study.
Topics: Adult; Aged; Blood Glucose; Body Weight; Clinical Trials as Topic; Diabetes Mellitus; Female; Glipiz | 1978 |
[Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)].
Topics: Administration, Oral; Aged; Biological Availability; Blood Glucose; Circadian Rhythm; Clinical Trial | 1975 |
Combination of two sulfonylureas. Does it make sense.
Topics: Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Therapy, | 1988 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythro | 1985 |
3 other studies available for glipizide and Glycosuria
Article | Year |
---|---|
[SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!].
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glipizide; Glucosides; Glycated Hemoglobin; Glycosu | 2013 |
Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance.
Topics: Adolescent; Adult; Child; Cystic Fibrosis; Female; Glipizide; Glucose Intolerance; Glycated Hemoglob | 1994 |
[A clinical study of a new sulfonylures hypoglycemic agent: glipizide (glibenese)(author's transl)].
Topics: Acetone; Aged; Blood Glucose; Chemical Phenomena; Chemistry; Delayed-Action Preparations; Diabetes M | 1975 |